Resources

Webinars

Return to listings page

May 11, 2011

Long-Acting Opioid Class REMS: An Update of New Requirements and Implications for Us All

Last month FDA issued requirements for the long awaited Long-Acting Opioid Class REMS programs. This webinar will focus on the components of the program and the implications and precedents for industry.

Overview:

  • Review the Long-Acting Opioids Class REMS components
  • Explore the implications for manufacturers
  • Discuss the precedents established for industry


Presenter:
Jeff Fetterman, President - ParagonRx


Webinar Slide Set:

 

 

 

 

 

 

 

 

 

Session Replay:




To speak to a ParagonRx team member about our monthly webinars
call 888.459.8080 or email info@paragonrx.com